SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BORGATTI, Monica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.847
AS - Asia 15.343
EU - Europa 12.984
SA - Sud America 2.533
Continente sconosciuto - Info sul continente non disponibili 723
AF - Africa 344
OC - Oceania 50
AN - Antartide 1
Totale 62.825
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.987
SG - Singapore 5.579
FI - Finlandia 4.212
CN - Cina 4.129
IT - Italia 2.286
BR - Brasile 1.999
VN - Vietnam 1.550
DE - Germania 1.331
HK - Hong Kong 1.220
UA - Ucraina 1.199
PL - Polonia 1.187
TR - Turchia 816
GB - Regno Unito 798
SE - Svezia 502
FR - Francia 499
CA - Canada 394
RU - Federazione Russa 380
JP - Giappone 365
IN - India 331
BD - Bangladesh 312
ID - Indonesia 242
MX - Messico 209
AR - Argentina 182
NL - Olanda 137
ZA - Sudafrica 119
IQ - Iraq 105
PK - Pakistan 96
EC - Ecuador 92
ES - Italia 87
CO - Colombia 81
PH - Filippine 65
VE - Venezuela 62
MY - Malesia 61
BE - Belgio 60
IR - Iran 57
UZ - Uzbekistan 54
SA - Arabia Saudita 52
MA - Marocco 47
LT - Lituania 46
AE - Emirati Arabi Uniti 42
CL - Cile 42
AT - Austria 40
JM - Giamaica 38
AU - Australia 37
CR - Costa Rica 37
TN - Tunisia 33
PY - Paraguay 32
KE - Kenya 31
CH - Svizzera 30
KR - Corea 30
CZ - Repubblica Ceca 28
EG - Egitto 28
HN - Honduras 28
IL - Israele 26
NI - Nicaragua 25
GR - Grecia 24
TH - Thailandia 24
SV - El Salvador 22
TT - Trinidad e Tobago 22
JO - Giordania 21
GT - Guatemala 20
IE - Irlanda 20
NP - Nepal 17
ET - Etiopia 16
PE - Perù 16
PT - Portogallo 16
TW - Taiwan 16
DZ - Algeria 15
LB - Libano 15
OM - Oman 15
AZ - Azerbaigian 14
KZ - Kazakistan 14
RO - Romania 14
LV - Lettonia 13
PA - Panama 13
BO - Bolivia 12
PR - Porto Rico 12
UY - Uruguay 12
DO - Repubblica Dominicana 11
EE - Estonia 10
NG - Nigeria 10
NZ - Nuova Zelanda 10
BG - Bulgaria 9
BH - Bahrain 9
CW - ???statistics.table.value.countryCode.CW??? 9
KG - Kirghizistan 9
KW - Kuwait 8
LY - Libia 8
PS - Palestinian Territory 8
RS - Serbia 8
AL - Albania 7
BB - Barbados 7
HU - Ungheria 7
SI - Slovenia 7
AO - Angola 6
GE - Georgia 6
GP - Guadalupe 6
MN - Mongolia 6
SY - Repubblica araba siriana 6
EU - Europa 5
Totale 62.012
Salva come PNG Salva come JPEG
Città #
Helsinki 3.850
Ashburn 3.654
Singapore 3.462
Woodbridge 2.259
San Jose 2.163
Fairfield 1.906
Beijing 1.481
Chandler 1.407
Jacksonville 1.371
Ann Arbor 1.296
Council Bluffs 1.265
Houston 1.231
Santa Clara 1.202
Hong Kong 1.196
Warsaw 1.169
Wilmington 804
Seattle 786
Cambridge 630
Ferrara 523
Ho Chi Minh City 509
Izmir 477
New York 452
Los Angeles 449
Dallas 431
Nanjing 425
Hanoi 362
Tokyo 341
Princeton 333
Lauterbourg 273
Munich 256
Boardman 234
Milan 216
Shanghai 177
São Paulo 168
San Diego 165
Jakarta 162
Bremen 154
Bologna 153
Addison 152
Phoenix 142
Nanchang 123
Mexico City 122
Shenyang 120
Rome 119
Toronto 111
Orem 108
London 103
Chicago 97
Brooklyn 95
Tianjin 93
Turku 93
Montreal 87
Changsha 85
Buffalo 84
Hebei 84
Redwood City 82
Porto Alegre 79
Chennai 78
Denver 78
Da Nang 75
Atlanta 74
Hefei 74
Rio de Janeiro 74
Falls Church 73
San Francisco 73
Jiaxing 68
Frankfurt am Main 67
Moscow 66
Stockholm 65
Johannesburg 64
Haiphong 63
Dearborn 61
Guangzhou 61
The Dalles 59
Brussels 56
Mountain View 54
Jinan 51
Falkenstein 49
Naples 49
Tashkent 49
Baghdad 48
Boston 46
Poplar 46
Auburn Hills 45
Verona 44
Manchester 43
Philadelphia 43
Brasília 42
Hangzhou 42
Norwalk 42
Washington 42
Guayaquil 39
Belo Horizonte 38
Mumbai 38
Des Moines 37
Zhengzhou 36
Curitiba 35
Dong Ket 35
Charlotte 34
Ningbo 34
Totale 41.661
Salva come PNG Salva come JPEG
Nome #
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 2.045
Use of angelicin and of its structural analogues for the treatment of thalassemia 1.985
A validated cellular biobank for β-thalassemia 446
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 443
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 400
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 391
Ground state naïve pluripotent stem cells and CRISPR/Cas9 gene correction for β-thalassemia 389
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 387
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 334
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 325
CARATTERIZZAZIONE CHIMICA E BIOATTIVITÀ DI PREPARAZIONI TRADIZIONALI DI DROGHE AYURVEDICHE: HEMIDESMUS INDICUS E AZADIRACHTA INDICA 323
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 317
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 304
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 294
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 287
A dielectrophoretic microchip for controlled cell targeting with functionalized microspheres 286
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 284
Alternate PNA-DNA chimeras (PNA-DNA)(n): synthesis, binding properties and biological activity 277
SPR-based non-invasive prenatal testing for fetal sex determination 277
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 273
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 272
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 269
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 267
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 265
A peptide nucleic acid against microrna miR-145-5p enhances the expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells 262
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 260
Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA 257
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 256
Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines 252
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 252
Droplet Digital PCR for Non-Invasive Prenatal Detection of Fetal Single-Gene Point Mutations in Maternal Plasma 251
Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis 249
Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin 249
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs 248
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 247
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 247
Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum 246
Expression of Pro-inflammatory Interleukin-8 is Reduced by Ayurvedic Decoctions 244
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 242
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 242
Biosensor technology and surface plasmon resonance for real-time detection of genetically modified Roundup Ready soybean gene sequences 239
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 239
"Lab-on-a-Chip" devices for cellular array based on dielectrophoresis 239
The biocompatibility of materials used in printed circuit board technologies with respect to primary neuronal and K562 cells 238
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 238
Targeting Transcription Factor Activity as a Strategy to Inhibit Pro-Inflammatory Genes Involved in Cystic Fibrosis: Decoy Oligonucleotides and Low-Molecular Weight Compounds 238
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 238
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 236
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 234
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae 234
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 233
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 231
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 231
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 231
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 228
Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites 227
Regulation of IL-8 gene expression in gliomas by microRNAs 227
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 226
Modulation of expression of IL-8 gene in bronchial epithelial cells by 5-methoxypsoralen 224
Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells 224
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 223
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 222
Antiproliferative and Erythroid Differentiation Activities of Cedrus libani Seed Extracts against K562 Human Chronic Myelogenus Leukemia Cells 222
A NOVEL USE OF RAPAMYCN AND STRUCTURAL ANALOGUES THEREOF 222
Liposomes as carriers for DNA-PNA hybrids 217
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 217
Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR 216
Digital microfluidic devices for isothermal circular strand displacement polymerization of microRNAs 215
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 214
New trends in non-invasive prenatal diagnosis: Applications of dielectrophoresis-based Lab-on-a-chip platforms to the identification and manipulation of rare cells (Review) 213
Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles 213
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 213
Cellular biosensors for the identification of fetal hemoglobin inducers 212
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 212
In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa 212
Alteration of microRNA biological activity with peptide nucleic acid 211
Cellulose acetate microparticles for Lab-on-a-chip applications 210
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 208
Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression 208
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 206
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 205
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 205
Plants with antitumor properties:from biologically active molecules to drugs 203
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 203
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 203
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 203
Gene Modulation by Peptide Nucleic Acids (PNAs) Targeting microRNAs (miRs) 202
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 201
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 200
A peptide nucleic acid targeting the acpP gene of Pseudomonas aeruginosa inhibits bacterial induced biological alterations in cystic fibrosis cells 199
Development and molecular characterization of transgenic mice for beta-thalassemia 198
"Lethal kiss” on a dielectrophoresis (DEP) based Lab-on-a-chip device: two-colour real-time determination of cytotoxic T-lymphocyte activity. 198
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 196
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 196
Development of microRNA based protocols for detection of autologous blood transfusion in sport 196
A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 196
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 196
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 195
Effects of Medicinal Plant Extracts on Molecular Interactions between DNA and Transcription Factors 195
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 193
Totale 28.068
Salva come PNG Salva come JPEG
Categoria #
all - tutte 265.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.760
Totale 273.222
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.462 0 0 0 105 212 161 156 139 126 279 349 935
2022/20233.300 353 266 81 444 569 447 150 298 367 33 160 132
2023/20241.875 142 262 79 49 211 366 119 87 31 30 76 423
2024/20257.091 182 189 580 355 789 556 239 381 1.199 816 955 850
2025/202623.264 1.905 791 1.605 2.377 2.748 1.285 2.384 1.167 5.634 2.270 753 345
2026/20275.884 575 1.201 2.052 2.056 0 0 0 0 0 0 0 0
Totale 62.825